Cargando…
Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR
Passive immunotherapy, i.e., treatment with therapeutic antibodies, has been increasingly used over the last decade in several diseases such as cancers or inflammation. However, these proteins have some limitations that single-domain antibodies could potentially solve. One of the main issues of conv...
Autores principales: | Pothin, Elodie, Lesuisse, Dominique, Lafaye, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601373/ https://www.ncbi.nlm.nih.gov/pubmed/33007904 http://dx.doi.org/10.3390/pharmaceutics12100937 |
Ejemplares similares
-
Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody
por: Cheong, Wei Shien, et al.
Publicado: (2020) -
The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles
por: Fernández-Quintero, Monica L., et al.
Publicado: (2022) -
Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (Chiloscyllium plagiosum)
por: Zhao, Linfei, et al.
Publicado: (2022) -
Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern
por: Valdovino-Navarro, Blanca J., et al.
Publicado: (2022) -
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
por: van Schie, Loes, et al.
Publicado: (2023)